Literature DB >> 24739752

Clinical outcomes of endoscopic and open resection of recurrent sinonasal inverted papilloma.

Feng-Ming Gu1, Lian-Shan Zhang.   

Abstract

PURPOSE: The aim of this study was to investigate the effectiveness of endoscopic surgery for recurrent sinonasal inverted papilloma and evaluate the recurrence rates of endoscopic and open resection at a single institution.
METHODS: This retrospective study was performed on 21 patients with histopathologically confirmed recurrent sinonasal inverted papilloma who underwent an operation in our department from January 1990 to January 2005. The 21 recurrent cases were categorized according to the Krouse staging system into 1 case of stage 1 (5%), 18 cases of stage 2 (85%), 2 cases of stage 3 (10%), and 0 cases of stage 4 (0%). There were 7 patients (33%) who underwent endoscopic resection and 14 patients (67%) who underwent open resection.
RESULTS: Of the 21 recurrent patients who underwent resection, 4 patients (19%) were found to have recurrence. The mean time to recurrence was 28 months. The recurrence rates of the patients with stage 1, stage 2, and stage 3 were 0%, 17%, and 50%, respectively (P < 0.05). Recurrence was observed in 1 patient (14%) in the endoscopic group and 3 patients (21%) in the open group (P > 0.05). There was statistical difference in recurrence rates between stage 1 and stage 2 in the endoscopic group (P < 0.05) and between stage 2 and stage 3 in the open group (P < 0.05). There was no significant difference in recurrence rates between the endoscopic and the open group in stage 2 (P > 0.05).
CONCLUSIONS: Endoscopic and open approaches are both available to achieve radical excision of the recurrent sinonasal inverted papilloma, with similar rates of recurrence. The risk for recurrence is likely related to the Krouse stage of the tumor, with more aggressive tumors having a higher propensity for recurrence. Endoscopic surgery is an effective treatment of recurrent sinonasal inverted papilloma.

Entities:  

Mesh:

Year:  2014        PMID: 24739752     DOI: 10.1097/SCS.0000000000000560

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  5 in total

1.  Inverted Papilloma of the Maxillary Sinus: A Recurrence Analysis According to Surgical Approaches.

Authors:  Jin Youp Kim; Su Hwan Kim; Pilkeun Jang; Yuju Seo; Sung-Woo Cho; Jeong-Whun Kim; Doo Hee Han; Hyun Jik Kim; Dong-Young Kim; Chae-Seo Rhee; Tae-Bin Won
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

2.  Metallothionein 2A core promoter region genetic polymorphism and its impact on the risk, tumor behavior, and recurrences of sinonasal inverted papilloma (Schneiderian papilloma).

Authors:  Katarzyna Starska; Magdalena Bryś; Ewa Forma; Jurek Olszewski; Piotr Pietkiewicz; Iwona Lewy-Trenda; Olga Stasikowska-Kanicka; Marian Danilewicz; Anna Krześlak
Journal:  Tumour Biol       Date:  2015-06-03

Review 3.  Surgical management of inverted papilloma; a single-center analysis of 247 patients with long follow-up.

Authors:  Oisín Bugter; Dominiek André Monserez; Floris Vincent Willem Joseph van Zijl; Robert Jan Baatenburg de Jong; Jose Angelito Hardillo
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-12-20

4.  Intranasal endoscopic prelacrimal recess approach for maxillary sinus inverted papilloma.

Authors:  Qian-Qian Yu; Ge Guan; Nian-Kai Zhang; Xiao-Wen Zhang; Yan Jiang; Yuan-Yuan Lian; Ting-Ting Liu; Xiao-Dan Jiang; Na Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-04       Impact factor: 2.503

5.  The analysis of expression of p16 protein in group of 53 patients treated for sinonasal inverted papilloma.

Authors:  Roland Zydroń; Andrzej Marszałek; Magdalena Bodnar; Paweł Kosikowski; Grażyna Greczka; Małgorzata Wierzbicka
Journal:  Braz J Otorhinolaryngol       Date:  2017-04-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.